Announcement of the Resolution of the Sixth Meeting of the Fourth Supervisory Board
release time:
2025-04-24 14:12
Announcement of the Resolution of the Sixth Meeting of the Fourth Supervisory Board
AnnouncementNumber: 2025-006
Stock code: 832316 Securities abbreviation: Tian Zheng Biotech Host brokerage: Shenwan Hongyuan underwriting sponsor
Jilin Tianzheng Biotechnology Co., Ltd
Announcement of the Resolution of the Sixth Meeting of the Fourth Supervisory Board
| The Company and all members of the Supervisory Board guarantee the authenticity, accuracy and completeness of the content of this announcement, and there are no false records, misleading statements or material omissions. They shall bear individual and joint legal responsibilities for the authenticity, accuracy and completeness of the content. |
I. Meeting Convening and Attendance
(1) Meeting convening situation
The meeting will be held on April 22, 2025
2. Meeting venue: Conference Room on the third floor of the company
3. Meeting format: It will be held on-site
4. Time and method for issuing the notice of the supervisory board meeting: It will be issued in writing on April 12, 2025
5. Chairperson of the meeting: Ms. Li Xiaoting, Chairperson of the Supervisory Board
6. Explanation of the legality and compliance of the convening situation:
The convening and holding of this meeting comply with the relevant provisions of the Company Law and other laws, regulations and the Company's Articles of Association.
(II) Attendance at the meeting
Three supervisors were supposed to attend the meeting, and three supervisors attended or were authorized to attend.
Ii. Review of the Motion
(1) The proposal on the "2024 Annual Report of the Supervisory Board of the Company" was reviewed and approved
1. Content of the motion:
"2024 Annual Report of the Supervisory Board"
2. Voting result of the motion: 3 votes in favor; 0 votes against; There were 0 abstentions.
3. Abstained from voting
None.
This motion still needs to be submitted to the shareholders' meeting for deliberation.
(2) The proposal on the Company's "2024 Financial Settlement Report" was reviewed and approved
1. Content of the motion:
"2024 Financial Settlement Report"
2. Voting result of the motion: 3 votes in favor; 0 votes against; There were 0 abstentions.
3. Abstained from voting
None.
This motion still needs to be submitted to the shareholders' meeting for deliberation.
(3) The proposal on the Company's "2025 Financial Budget Plan" was reviewed and approved
1. Content of the motion:
"Financial Budget Plan for 2025"
2. Voting result of the motion: 3 votes in favor; 0 votes against; There were 0 abstentions.
3. Abstained from voting
None.
This motion still needs to be submitted to the shareholders' meeting for deliberation.
(4) The proposal on the Company's "Profit Distribution Plan for 2024" was reviewed and approved
1. Content of the motion:
In order to enhance the financial stability, strengthen the ability to resist risks, achieve the company's sustained, stable and healthy development, and better safeguard the long-term interests of all shareholders, based on the actual situation of the company, after research and decision by the board of directors: no profit distribution for the year 2024 will be made.
2. Voting result of the motion: 3 votes in favor; 0 votes against; There were 0 abstentions.
3. Abstained from voting
None.
This motion still needs to be submitted to the shareholders' meeting for deliberation.
(V) The proposal on the Company's "2024 Annual Report and Abstract of the 2024 Annual Report" was reviewed and approved
1. Content of the motion:
In accordance with the "Information Disclosure Rules for Listed Companies on the National Equities Exchange and Quotations System" and the "Notice on Doing a Good Job in the Disclosure of 2024 Annual Reports of Listed Companies" issued by the National Equities Exchange and Quotations System Co., LTD., the company's supervisory board has reviewed the company's "2024 Annual Report" and issued the following review opinions:
The procedures for the preparation and review of the annual report comply with laws and regulations, the provisions of the China Securities Regulatory Commission, the National Equities Exchange and Quotations Co., LTD., as well as the provisions of the company's articles of association and internal management systems.
2. The content and format of the annual report comply with the provisions of the "Content and Format Standards for Information Disclosure by Non-listed Public Companies No. 9 - Annual Reports of Companies Listed on the Innovation Layer". No information in the company's 2024 annual report was found to be inconsistent with the actual situation. The company's 2024 annual report truly reflects the company's operating results and financial position for the year 2024.
Before putting forward this opinion, no violations of confidentiality regulations were found among the personnel involved in the preparation and review of the annual report.
In addition, all members of the supervisory board also attended the 10th meeting of the 4th board of directors of the company as non-voting participants and performed the duties of supervisors in accordance with the law.
2. Voting result of the motion: 3 votes in favor; 0 votes against; There were 0 abstentions.
3. Abstained from voting
None.
This motion still needs to be submitted to the shareholders' meeting for deliberation.
Iii. Directory of Reference Documents
Resolution of the Sixth Meeting of the Fourth Supervisory Board of Jilin Tianzheng Biotechnology Co., LTD.
The Written Review Opinion of the Supervisory Board on the 2024 Annual Report
Jilin Tianzheng Biotechnology Co., LTD
Supervisory Board
April 22, 2025
Related news
service
Address
167# Changbai Mountain Avenue, Jiaohe, Jilin Province